Eli Lilly and Company
Eli Lilly and Company (LLY.TO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · LLY.TO · as of Jun 8, 2026
Key Statistics
Explore Eli Lilly and Company Data
lly.to stock data · financialsStock Performance
Full HistoryAbout Eli Lilly and Company
Eli Lilly and Company Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products an…
what is eli lilly and company · lly.to stock overview · eli lilly and company company profile · who is eli lilly and company ceo · lly.to TSX · eli lilly and company headquarters · eli lilly and company business segments
About Stock Overview & Key Data
Eli Lilly and Company (LLY.TO) is a Healthcare company in the Medical - Pharmaceuticals industry, listed on TSX since Dec 22, 2025. As of the latest trading session, LLY.TO stock price is $40.68, with a market capitalization of $1.40T. The stock has returned +4.09% over the past 12 months and +4.09% year-to-date.
Frequently Asked Questions
As of the latest trading session, Eli Lilly and Company (LLY.TO) stock price is $40.68. The stock is traded on TSX under the ticker symbol LLY.TO. The 52-week range is $30.67 – $41.89.